(Olaparib/Lynparza) New ovarian cancer drug shown to prolong lives approved for use in Scotland Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, November 10, 2016

(Olaparib/Lynparza) New ovarian cancer drug shown to prolong lives approved for use in Scotland



media


The drug, also known as Lynparza, is already in use in the USA, Europe and England and this week the Scottish Medicines Consortium permitted its use in Scotland.
It will also be used for those with fallopian tube and peritoneal cancers and could eventually treat a wide range of cancer types, including breast and pancreatic cancer.

0 comments :

Post a Comment

Your comments?